PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 48 filers reported holding PROTARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,409 | +69781.8% | 209,227 | 0.0% | 0.02% | -17.4% |
| Q2 2023 | $500 | -23.7% | 209,227 | 0.0% | 0.02% | -28.1% |
| Q1 2023 | $655 | -99.9% | 209,227 | 0.0% | 0.03% | +6.7% |
| Q4 2022 | $560,728 | -9.4% | 209,227 | 0.0% | 0.03% | -14.3% |
| Q3 2022 | $619,000 | +1.0% | 209,227 | 0.0% | 0.04% | -10.3% |
| Q2 2022 | $613,000 | -42.7% | 209,227 | 0.0% | 0.04% | -29.1% |
| Q1 2022 | $1,069,000 | -24.3% | 209,227 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $1,412,000 | -2.5% | 209,227 | 0.0% | 0.06% | +7.8% |
| Q3 2021 | $1,448,000 | -28.9% | 209,227 | 0.0% | 0.05% | -29.2% |
| Q2 2021 | $2,038,000 | -38.1% | 209,227 | 0.0% | 0.07% | -35.7% |
| Q1 2021 | $3,293,000 | -35.0% | 209,227 | 0.0% | 0.11% | -31.3% |
| Q4 2020 | $5,065,000 | +43.9% | 209,227 | 0.0% | 0.16% | +33.6% |
| Q3 2020 | $3,521,000 | – | 209,227 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $40,270,000 | 5.92% |
| Ikarian Capital, LLC | 649,542 | $10,223,000 | 0.34% |
| Rock Springs Capital Management LP | 689,942 | $10,860,000 | 0.24% |
| Cormorant Asset Management, LP | 350,000 | $5,509,000 | 0.12% |
| Maven Securities LTD | 172,177 | $2,508,000 | 0.11% |
| Boxer Capital, LLC | 209,227 | $3,293,000 | 0.11% |
| KNOTT DAVID M | 14,369 | $226,000 | 0.10% |
| Perceptive Advisors | 421,642 | $6,637,000 | 0.08% |
| Orbimed Advisors | 450,000 | $7,083,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 58,226 | $916,000 | 0.03% |